Evaluation of global transcription factor binding in breast cancer cells has indicated that GR and ER can mediate genomic cross-talk by regulating each other’s binding at recognition sites; this action allows rapid reprogramming of the chromatin structure and targeting of novel genes following the co-activation of both receptors (Miranda et al. 2013). This evidence concerns the gene NR3C1 and breast cancer.